Related Experiment Videos
MDM2--master regulator of the p53 tumor suppressor protein
1California State University at Los Angeles, Department of Chemistry and Biochemistry, 90032, USA. jmomand@calstatela.edu
Abstract:
MDM2 is an oncogene that mainly functions to modulate p53 tumor suppressor activity. In normal cells the MDM2 protein binds to the p53 protein and maintains p53 at low levels by increasing its susceptibility to proteolysis by the 26S proteosome. Immediately after the application of cellular stress, the ability of MDM2 to bind to p53 is blocked or altered in a fashion that prevents MDM2-mediated degradation. As a result, p53 levels rise, causing cell cycle arrest or apoptosis. In this review, we present evidence for the existence of three highly conserved regions (CRs) shared by MDM2 proteins and MDMX proteins of different species. These highly conserved regions encompass residues 42-94 (CR1), 301-329 (CR2), and 444-483 (CR3) on human MDM2. These three domains are respectively important for binding p53, for binding the retinoblastoma protein, and for transferring ubiquitin to p53. This review discusses the major milestones uncovered in MDM2 research during the past 12 years and potential uses of this knowledge in the fight against cancer.
Insights
MDM2 oncogene regulates the p53 tumor suppressor. Conserved regions in MDM2 are crucial for binding p53 and retinoblastoma protein, impacting cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MDM2 is an oncogene that regulates p53 tumor suppressor activity.
- MDM2 targets p53 for degradation in normal cells, maintaining low p53 levels.
- Cellular stress disrupts MDM2-p53 binding, increasing p53 levels and inducing cell cycle arrest or apoptosis.
Purpose of the Study:
- To review conserved regions in MDM2 and MDMX proteins.
- To highlight the functional significance of these conserved regions.
- To discuss recent advancements in MDM2 research and their therapeutic potential in cancer.
Main Methods:
- Review of existing literature on MDM2 and MDMX proteins.
- Analysis of conserved regions (CRs) across species.
- Discussion of functional domains within MDM2.
Main Results:
- Identification of three highly conserved regions (CR1, CR2, CR3) in MDM2 and MDMX.
- CR1 (residues 42-94) is essential for p53 binding.
- CR2 (residues 301-329) binds the retinoblastoma protein.
- CR3 (residues 444-483) is involved in ubiquitin transfer to p53.
Conclusions:
- The conserved regions of MDM2 are critical for its function in regulating p53.
- Understanding these regions offers insights into cancer mechanisms.
- MDM2 research holds potential for novel cancer therapies.